MA-CHAOSSEARCH
27.11.2023 15:06:32 CET | Business Wire | Press release
Today, ChaosSearch, a leader in data analytics, announced the integration of Chaos LakeDB with Amazon Bedrock from Amazon Web Services (AWS), a fully managed service that makes foundation models (FMs) from leading AI companies accessible via an API to build and scale generative AI applications. This integration is designed to transform the way organizations leverage generative artificial intelligence (AI) to interact with their unified data lakes for observability, security lakes, and application insight use cases, providing clients with enhanced simplicity, choice, and security. Chaos LakeDB customers can select any large language model (LLM) from Amazon Bedrock’s choice of high-performing FMs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231127237186/en/
The combination of generative AI and ChaosSearch’s unified data lake offers new possibilities for enterprises. Chaos LakeDB opens these opportunities while delivering cost-effective scaling and simplifying working with data pipelines, data preparation, and data islands. It integrates with and orchestrates pre-trained generative AI models as a complement to Search and SQL analytics, creating an ideal launch point for enterprises to immediately realize efficiency improvements across observability, security lake, and application insight use cases.
"As a long-term partner with ChaosSearch, we've witnessed firsthand the transformative impact of their technology on our data analytics capabilities," said Jimmy McDermott of PATHWAYos. "The integration of Chaos LakeDB with Amazon Bedrock represents a leap forward in our ability to harness the full power of generative AI within our data strategy. The seamless and secure interaction with LLMs has allowed us to tap into a new dimension of data intelligence, optimizing our workflows, and enhancing our decision-making process. ChaosSearch's vision for the future of data interaction is not just a promise; it's a reality that's delivering exceptional value to our organization."
Chaos LakeDB integration with Amazon Bedrock allows users to engage with their data through a conversational AI interface, leveraging public and private LLM models. By utilizing prompt engineering and orchestrating chain-of-thought interaction, users can converse directly with their data with enhanced security. The integration leverages AWS’s data security and privacy best practices and no confidential or proprietary data is shared with the LLM. Furthermore, this design removes the challenges of complex and costly model training while preventing data hallucinations.
With the integration of Chaos LakeDB with Amazon Bedrock, organizations can further isolate their data in a private workspace where all exchanges of information between the database and the LLM are private. None of the customer’s data is used to train or fine-tune the underlying LLM. In essence, the LLM is private to the user account.
Chaos LakeDB’s integration with Amazon Bedrock delivers:
- Intuitive Data Exploration: Understand complex data effortlessly with ChaosSearch AI Assistant's ability to suggest, process queries, and surface crucial insights, eliminating the barrier of advanced analytical skills.
- Code Co-pilot: Receive smart support for writing and refining Elastic and SQL queries, with the assurance of secure processing.
- Enhanced Team Collaboration: Promote efficient teamwork and shared understanding through user-friendly data sharing and exploration tools, suitable for various expertise levels.
- Immediate Insights: Obtain real-time visibility into key operational areas such as system behavior, security monitoring, and application performance.
"AI is transforming business intelligence," said Dr. Sherry Marcus, director of Applied Science of Amazon Bedrock and Amazon Titan at Amazon Web Services. "The Chaos LakeDB integration with Amazon Bedrock is simplifying how customers engage with and analyze their data—and with the security and scalability that enterprises demand. Using conversational queries to interact with their data, customers will be able to glean deeper insights and make more informed decisions. We look forward to seeing how the power of generative AI will enhance customers’ business strategies."
"At ChaosSearch, we are deeply passionate about empowering our clients to conquer the ever-growing mountain of data analytics challenges," said Thomas Hazel, founder and CTO of ChaosSearch. "The integration of Chaos LakeDB with Amazon Bedrock is a critical milestone on our ambitious roadmap. It's designed to provide a straightforward, high-impact entry point for organizations embarking on their generative AI journey. We're not just enhancing our platform; we're providing a key that unlocks high-value insights while simplifying the journey to scale analytics. Our dedication to innovation is relentless, and this integration exemplifies our commitment to delivering not just solutions but pathways to transformation and growth that redefine analytics at scale for our clients."
An innovative solution for data interaction and analysis, Chaos LakeDB's integration with Amazon Bedrock is a powerful tool for businesses worldwide. As the company moves forward with its dynamic roadmap, clients can anticipate even more advanced features and capabilities tailored to their specific needs. As clients look to train their own models or augment existing FMs, Chaos LakeDB will play a critical role for creation, test data access and exporting for training and deploying generative AI models in production at scale without breaking the bank.
Chaos LakeDB and the integration with Amazon Bedrock is available in early access. Contact us, for more information or to request a demo.
About ChaosSearch:
ChaosSearch is redefining the boundaries of data analytics by offering transformative solutions that empower businesses to make data-driven decisions with unparalleled efficiency. Our ethos is centered on simplifying complexity and turning challenges into opportunities. Chaos LakeDB is at the forefront of revolutionizing data lake architectures in the AI-driven era. By seamlessly transforming cloud storage into a dynamic analytical database, it integrates diverse data streams, streamlines intricate pipelines, and delivers at scale actionable insights through Search+SQL+GenAI analytics. By eliminating manual redundancies and activating static data lakes, Chaos LakeDB provides businesses with both real-time and historical intelligence. As champions of innovation, ChaosSearch is dedicated to delivering tools that not only meet but also anticipate the evolving needs of modern businesses. Dive into a world where data is not just stored but becomes a dynamic force driving growth and innovation.
Leading cloud-based organizations, including Equifax, Cisco, Revinate, and Digital River, trust the ChaosSearch Cloud Data Platform. For more information, visit ChaosSearch.io or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231127237186/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom